VIRAL HEPATITIS
Clinical trials for VIRAL HEPATITIS explained in plain language.
Never miss a new study
Get alerted when new VIRAL HEPATITIS trials appear
Sign up with your email to follow new studies for VIRAL HEPATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo takes on rare liver virus in head-to-head trial
Disease control OngoingThis study tests whether a combination of two experimental drugs (Tobevibart and Elebsiran) works better than the current treatment Bulevirtide for people with chronic hepatitis D, a serious liver infection. About 100 adults aged 18-70 with stable liver function are taking part. …
Matched conditions: VIRAL HEPATITIS
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 26, 2026 08:28 UTC
-
New drug duo aims to silence hepatitis delta virus
Disease control OngoingThis phase 3 study tests whether a combination of two experimental drugs, tobevibart and elebsiran, can control chronic hepatitis delta infection. About 124 adults with the virus will receive the combo either right away or after a delay. The main goal is to see if the drugs can m…
Matched conditions: VIRAL HEPATITIS
Phase: PHASE3 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 18, 2026 12:10 UTC